EP4376806A2 — Bupivacaine-collagen drug delivery implant and methods of making and using thereof
Assigned to Innocoll Pharmaceuticals Ltd · Expires 2024-06-05 · 2y expired
What this patent protects
In one aspect, the present disclosure provides a drug delivery device comprising a collagen matrix and an anesthetic drug substance. In another aspect, the present disclosure provides methods of isolating and maturing the collagen used to make the collagen matrix. In yet another …
USPTO Abstract
In one aspect, the present disclosure provides a drug delivery device comprising a collagen matrix and an anesthetic drug substance. In another aspect, the present disclosure provides methods of isolating and maturing the collagen used to make the collagen matrix. In yet another aspect, the present disclosure provides methods of making the drug delivery device from the matured collagen.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.